Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmion Corp.

Division of Celgene Corp.
www.pharmion.com

Latest From Cilag GMBH International

In Vivo's Deals Of The Month, June 2017

In Vivo's editors pick June's most significant deals, including Idorsia's IPO and Medtronic's outcomes-based contract with Aetna. (Free article.)

BioPharmaceutical Medical Device

NICE Backs Imbruvica In CLL On Price Cut Despite Outcome Uncertainties

It looks likely AbbVie. and Johnson & Johnson's Imbruvica (ibrutinib) will be made routinely available on the NHS in England and Wales for treating chronic lymphocytic leukemia after an undisclosed price cut was offered and data further considered by the UK HTA NICE.

United Kingdom Commercial

Deals Shaping The Medical Industry, November 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2016.

Deals Market Intelligence

In Vivo's Deals Of The Month, October 2016

In Vivo's editors pick October's most significant deals, including stealthy Carrick's big Series A and AstraZeneca's out-licensing spree. (Article free with registration.)

BioPharmaceutical Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celgene Corp.
  • Senior Management
  • Patrick J Mahaffy, Pres. & CEO
    Erle T Mast, EVP, CFO
    Andrew R Allen, PhD, EVP, CMO
  • Contact Info
  • Pharmion Corp.
    Phone: (720) 564-9100
    2525 28th St.
    Ste. 200
    Boulder, CO 80301
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register